Open access · CC-BY
via OpenAlex
The Interplay of Microbiome Dysbiosis and Cardiovascular Disease
Anas Zaher, Jude ElSaygh, Stephen J. Peterson, Ilan S. Weisberg, Manish A. Parikh, William H. Frishman
Cardiology in Review · 2024 · ▲ 17 citations
Abstract
The intricate ecosystem of the mammalian gut, which hosts a diverse microbiome, plays a vital role in various physiological functions. Trillions of bacteria within the gut contribute to host metabolism, immune modulation, energy homeostasis, and more. Emerging research highlights the gut microbiota's significant impact on cardiovascular diseases (CVDs), with intestinal dysbiosis identified as a risk factor for conditions such as obesity and diabetes, both linked to atherosclerosis. Chronic inflammation, pivotal in atherosclerosis, is influenced by the gut microbiome, where microbial signals, such as lipopolysaccharides, can translocate from the gut to trigger inflammatory responses. Diet has major effects on the gut microbiota, with the Western diet, rich in saturated fats, contributing to dysbiosis and elevated cardiovascular risks. Probiotics and prebiotics offer therapeutic potential in CVD management. Probiotics, or live microorganisms, exhibit antioxidant, anti-inflammatory, and cholesterol-lowering effects. Probiotics are most effective when given with prebiotics, with the former acting on the latter as substrate. Understanding the dynamic interplay between diet, gut microbiota, and CVD provides insights into preventive and therapeutic strategies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1097/crd.0000000000000701
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Zaher, A., ElSaygh, J., Peterson, S.J., Weisberg, I.S., Parikh, M.A., & Frishman, W.H. (2024). The Interplay of Microbiome Dysbiosis and Cardiovascular Disease. <em>Cardiology in Review</em>. https://doi.org/10.1097/crd.0000000000000701
Vancouver
Zaher A, ElSaygh J, Peterson SJ, Weisberg IS, Parikh MA, Frishman WH. The Interplay of Microbiome Dysbiosis and Cardiovascular Disease. Cardiology in Review. 2024. doi:10.1097/crd.0000000000000701.
BibTeX
@article{anas2024TheInt,
title = {The Interplay of Microbiome Dysbiosis and Cardiovascular Disease},
author = {Anas Zaher and Jude ElSaygh and Stephen J. Peterson and Ilan S. Weisberg and Manish A. Parikh and William H. Frishman},
journal = {Cardiology in Review},
year = {2024},
doi = {10.1097/crd.0000000000000701},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Saudi Journal of Biological Sciences 2021
Open access · CC-BY
Gut microbiota and immunity relevance in eubiosis and dysbiosis
Aging Pathobiology and Therapeutics 2025
Open access · CC-BY
Inflammaging and microbiota: the intersection of aging, inflammation, and gut health
International Journal of Molecular Sciences 2024
Open access · CC-BY
Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches
Diseases 2019
Open access · CC-BY
Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease
Genes and Immunity 2021
Open access · OA
The aging gut microbiome and its impact on host immunity
Frontiers in Medicine 2022
Open access · CC-BY